Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
10/31/2000 | US6140362 Method for inhibiting the growth of mammalian cells |
10/31/2000 | US6140358 Substituted phenyl keto enols as pesticides and herbicides |
10/31/2000 | US6140354 N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
10/31/2000 | US6140350 Applying neonicotinoid compound for controlling ectoparasites through blood of a host animal |
10/31/2000 | US6140331 For treating anxiety disorders, depression, psychosis, impulse control disorders, alcohol abuse, ischaemic diseases, cardiovascular disorders, side effects induced by conventional antipsychotic agents and senile dementia |
10/31/2000 | US6139865 Taste-masked microcapsule compositions and methods of manufacture |
10/31/2000 | CA2199703C Perfluorinated polymide, perfluorinated poly (amic acid), starting compounds therefor, and methods for preparing them |
10/26/2000 | WO2000063488A1 Process for the production of furfural from lignosulphonate waste liquor |
10/26/2000 | WO2000063328A1 Perfume precursor compositions and method for expressing perfume components |
10/26/2000 | WO2000063200A1 Preparation of norlabdane oxide |
10/26/2000 | WO2000063199A1 Process for the preparation of 3-hydroxytetrahydrofuran |
10/26/2000 | WO2000063198A1 2,2-disubstituted cyclic ether derivatives and hair tonics containing the same |
10/26/2000 | WO2000063165A1 Mmp inhibitor |
10/26/2000 | WO2000063153A1 New compounds, their preparation and use |
10/26/2000 | WO2000062926A1 Vanadyl pyrophosphate oxidation catalyst |
10/26/2000 | WO2000062925A1 Vanadium phosphorus oxide catalyst having a thermally conductive support |
10/26/2000 | WO2000026197A9 Novel inhibitors of impdh enzyme |
10/26/2000 | DE19917603A1 Preparation of 5-oxy-2,3-dihydro-2-furanones, including new compounds, by desilylating 3-silyl analogs using aluminum oxide, are potential biologically active agents |
10/26/2000 | CA2367356A1 New compounds, their preparation and use |
10/25/2000 | EP1046647A2 Group 8,9 or 10 transition metal catalyst for olefin polymerization |
10/25/2000 | EP1045831A1 Solid supported synthesis of hydroxamic acids |
10/25/2000 | EP0720601B1 Gastrin and cck receptor ligands |
10/25/2000 | CN1271353A Furansulfonic acid derivatives and pharmaceutical compositions containing the same |
10/25/2000 | CN1271352A Process for making 3-aryloxy, 4-arylfuran-2-ones useful as inhibitors of cox-2 |
10/25/2000 | CN1271346A Method for producing substituted 2-nitroguanidine derivative |
10/25/2000 | CN1271345A Method for producing substituted 2-nitroguanideine derivatives |
10/25/2000 | CN1271343A Utilizing spirocyclic phenyl keto-enols as pesticides and herbicides |
10/25/2000 | CN1270958A Beta-lactan |
10/24/2000 | US6137003 Bis (haloethyl) aminobenzene derivatives |
10/24/2000 | US6136985 CLA esters and uses thereof |
10/24/2000 | US6136845 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl PCDFs |
10/24/2000 | US6136832 Racemic mixtures and enantiomorphs |
10/24/2000 | US6136157 Method for organic reactions |
10/19/2000 | WO2000061571A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
10/19/2000 | WO2000061134A1 Antimicrobial agents |
10/19/2000 | DE19917178A1 Production of furfural from sulfite waste liquor involves heating by direct injection of steam, reaction by boiling under pressure, using easily separated ancillary, and complete vaporization by cooling and depressurization |
10/19/2000 | DE19915602A1 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-4-arylpropan-1-ol-derivatives, their preparation and use |
10/19/2000 | DE19915601A1 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-3-arylpropan-1-ol-derivatives, their preparation and use |
10/19/2000 | DE19911504A1 Verfahren zur industriellen Oxidation von Alkoholen, Aldehyden oder Polyhydroxyverbindungen A process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds |
10/18/2000 | EP1044972A1 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVE AND DRUGS CONTAINING THE SAME |
10/18/2000 | EP1044226A1 Method for coupling living cationic polymers |
10/18/2000 | CN1270588A Method for purifying phthalides |
10/18/2000 | CN1270163A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
10/18/2000 | CN1270162A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
10/18/2000 | CN1057443C Method for preparing antiviral medicinal compositions |
10/17/2000 | US6133464 May be used as ligands for transition metal catalysts in enantioselective reactions |
10/17/2000 | US6133446 Heterocyclic compounds for the treatment of CNS and cardiovascular disorders |
10/17/2000 | US6133409 Reacting a solid support-bound n-alkylated hydroxamic acid with a carbon-nitrogen cleaving organometallic compund to liberate the product ketone |
10/17/2000 | US6133292 Diaryl-5-alkyl-5-methyl-2-(5H)-furanones as selective cyclooxygenase-2-inhibitors |
10/17/2000 | US6133279 Therapeutic agents for renal diseases and organ preservatives |
10/17/2000 | US6133263 For treating elevated levels of endothelin, angina, arrhythmias, asthma, atherosclerosis, benign prostatic hyperplasia, chrohn's disease, congenital heart disease, congestive heart failure, congestive heart failure |
10/17/2000 | US6133238 Tetrahydrofurans |
10/17/2000 | US6133184 An oxidation catalyst for synthesis of aromatic anhydride and nitrile consists of a silicon carbide carrier, an inorganic oxide binder selected from oxides of niobium or antimony or tungsten, and a catalyst selected from vanadium or molybdenum |
10/17/2000 | US6132475 For oxidation dyeing of keratin fibers; includes coupler and developer, in which the developer is a substituted 2-(furyl, thienyl, pyrrolyl, or selenophene) p-diaminobenzene derivative of given formula; colorfastness, washfastness |
10/12/2000 | WO2000060027A2 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring |
10/12/2000 | WO2000059946A1 Hydroxymatairesinol in cancer prevention |
10/12/2000 | WO2000059880A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
10/12/2000 | WO2000059878A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
10/12/2000 | WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
10/12/2000 | WO2000059506A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
10/12/2000 | WO1998025597A3 Method for treating and preventing heart failure and ventricular dilatation |
10/12/2000 | WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
10/12/2000 | CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
10/12/2000 | CA2369005A1 Inhibitors of lfa-1 binding to icams and uses thereof |
10/11/2000 | EP1043307A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use |
10/11/2000 | EP1043306A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and use |
10/11/2000 | EP1042319A1 Dihydrobenzofurans |
10/11/2000 | EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
10/11/2000 | EP1042310A2 Method for the preparation of citalopram |
10/11/2000 | EP1042305A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
10/11/2000 | EP1042280A2 Prodrugs of aspartyl protease inhibitors |
10/11/2000 | EP1042279A1 Substituted beta-alanines |
10/11/2000 | EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
10/11/2000 | EP1042272A1 Derivatives of 2,2-dimethyl 3-(2-fluoro vinyl) cyclopropane carboxylic acid, their preparation process and their use as pesticides |
10/11/2000 | EP1041980A1 Acyl guanidine sodium/proton exchange inhibitors and method |
10/11/2000 | EP1041979A1 Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof |
10/11/2000 | EP0773930B1 Aromatic amino ethers as pain relieving agents |
10/11/2000 | EP0703971B1 Use of n,n-diacetic alpha-alanine and its salts as biodegradable complexing agents for alkaline earth and heavy metal ions in cleaning compositions for dishwashing |
10/11/2000 | EP0650485B1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
10/11/2000 | CN1269795A Method for preparing alkyloxy furnanone derivatives, compounds obtained by said method and use of said compounds |
10/11/2000 | CN1269775A Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system |
10/10/2000 | US6130349 Catalytic compositions and methods for asymmetric allylic alkylation |
10/10/2000 | US6130257 Compositions of enantiomeric diacyl tartaric anhydrides and preparation thereof |
10/10/2000 | US6130251 Use as agents for combating pests. |
10/10/2000 | US6130240 Compound for treatment of cardiac arrhythmia, synthesis, and methods of use |
10/10/2000 | US6130226 Immunotherapeutic agents |
10/10/2000 | US6130222 Analgesics |
10/07/2000 | CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use |
10/07/2000 | CA2303721A1 3-amino-3-arylpropan-1-ol derivatives, their preparation and use |
10/05/2000 | WO2000058299A1 Method of preparing benzofurandione oxime derivatives |
10/05/2000 | WO2000058298A2 PROCESS FOR THE PREPARATION OF α-METHYLENELACTONES AND α-SUBSTITUTED HYDROCARBYLIDENE LACTONES |
10/05/2000 | WO2000058297A2 PROCESS FOR THE PREPARATION OF α-METHYLENE LACTONES |
10/05/2000 | WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
10/05/2000 | WO2000058256A1 Process for the preparation of 3,4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars |
10/05/2000 | WO2000057701A1 Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
10/05/2000 | CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
10/05/2000 | CA2362124A1 Process for the preparation of .alpha.-methylenelactones and .alpha.-substituted hydrocarbylidene lactones |
10/05/2000 | CA2361037A1 Process for the preparation of .alpha.-methylene lactones |
10/05/2000 | CA2359652A1 Novel prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of peripheral vascular disease and pulmonaryhypertension |
10/04/2000 | EP1040103A1 Anilide derivative, production and use thereof |